Could a COVID shot boost liver cancer treatment?

NCT ID NCT07341321

First seen Jan 27, 2026 · Last updated May 13, 2026 · Updated 13 times

Summary

This study looks back at medical records of 200 liver cancer patients in Austria to see if getting an mRNA COVID-19 vaccine within three months before starting immunotherapy improves their response to cancer treatment. Researchers will also check if vaccination affects survival or side effects. The goal is to understand if timing the vaccine with immunotherapy can lead to better outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Klinikum Wels-Grieskirchen

    Wels, Austria

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Krankenhaus der Barmherzigen Brüder St Veit an der Glan

    Sankt Veit an der Glan, Austria

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Medical University of Graz

    Graz, 8010, Austria

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Ordensklinikum Linz

    Linz, Austria

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University Hospital St. Pölten

    Sankt Pölten, Austria

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.